← Eichor
Study identifier: NCT07477483 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Manuel Therapy on Tension Type Headache in Menopausal and Premenopasual Women

Condition: Tension Type Headache  ·  Sponsor: Necmettin Erbakan University

PhaseNA
Planned participants50
Who can joinFemale, 45 Years to 65 Years
Healthy volunteersNo

About this study

This study aims to investigate the effectiveness of manual therapy in women with tension-type headache and to compare treatment outcomes between menopausal and premenopausal women. Hormonal changes occurring during menopause may influence pain perception and headache characteristics. Participants diagnosed with tension-type headache will receive manual therapy interventions. Headache intensity, headache-related disability, pressure pain threshold, cervical range of motion, sleep quality, and quality of life will be evaluated before and after treatment using validated assessment tools. The results are expected to contribute to physiotherapy approaches in women experiencing tension-type headache during different hormonal periods.

This description comes directly from the study's public registry record.

Talk to the study team

Ayça Seda Yıldırımer, PT, MSc  ·  +90 507 409 08 99  ·  aycaseda29@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Necmettin Erbakan Univesity Faculty of Health SciencesKonya, Konya, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07477483